SymbolHYPD
NameHYPERION DEFI, INC.
SectorHEALTH CARE
RegionNorth America
IndustryBiotechnology: Pharmaceutical Preparations
Address295 MADISON AVENUE,SUITE 2400, NEW YORK, New York, 10017, United States
Telephone+1 917 289-1117
Fax
Email
Websitehttps://www.eyenovia.com
IncorporationUNDEFINED
Incorporated On
Employees
Fiscal Year
Public Since
ExchangesNASDAQ
Auditor
Audit StatusNOT PROVIDED
Reporting Status
CIK0001682639
Description

Eyenovia Inc is a clinical stage ophthalmic company developing a pipeline of therapeutics based on its propriety array print (MAP) platform technology. It aims to achieve clinical microdosing of next-generation formulations of novel and existing ophthalmic pharmaceutical agents using its high-precision targeted ocular delivery system, branded the Opejet, which has the potential to replace conventional eye dropper delivery and improve safety, tolerability, patient compliance and topical delivery success for ophthalmic eye treatments. Using its proprietary delivery technology, Eyenovia is developing the next generation of smart ophthalmic therapies which target new indications or new combinations.

Additional info from NASDAQ:
Eyenovia Inc is a clinical stage ophthalmic company developing a pipeline of therapeutics based on its propriety array print (MAP) platform technology. It aims to achieve clinical microdosing of next-generation formulations of novel and existing ophthalmic pharmaceutical agents using its high-precision targeted ocular delivery system, branded the Opejet, which has the potential to replace conventional eye dropper delivery and improve safety, tolerability, patient compliance and topical delivery success for ophthalmic eye treatments. Using its proprietary delivery technology, Eyenovia is developing the next generation of smart ophthalmic therapies which target new indications or new combinations.

2026-08-12 20:01

Hyperion DeFi Reports 2Q 2026 Financial Results with Another Record Quarterly Net Income and Strong Operating Momentum

Read more
2026-07-29 14:21

Hyperion DeFi Schedules First Quarter Earnings Call for Wednesday, August 12 at 5:00 p.m. ET

Read more
2026-07-15 17:00

Hyperion DeFi Enters Agreement with Skew Technologies to Launch HIP-3 Perpetual Futures Market and Listing Service

Read more
2026-07-08 13:01

(99% Neutral) HYPERION DEFI, INC. (HYPD) Announces New Board Appointment

Read more
2026-07-01 20:02

Director Strahlman Ellen R 🟢 acquired 58.9K shares of HYPERION DEFI, INC. (HYPD) Transaction Date: Jun 30, 2026 | Filing ID: 079860

Read more
2026-07-01 20:01

Director JACOBSON RACHEL 🟢 acquired 58.9K shares of HYPERION DEFI, INC. (HYPD) Transaction Date: Jun 30, 2026 | Filing ID: 079859

Read more
2026-07-01 20:01

(99% Neutral) HYPERION DEFI, INC. (HYPD) Announces Regulatory Update

Read more
2026-07-01 20:01

Director GELTZEILER MICHAEL S 🟢 acquired 58.9K shares of HYPERION DEFI, INC. (HYPD) Transaction Date: Jun 30, 2026 | Filing ID: 079858

Read more
2026-07-01 10:16

New Form SCHEDULE 13G/A - HYPERION DEFI, INC. <b>Filed:</b> 2026-07-01 <b>AccNo:</b> 0001104659-26-079631 <b>Size:</b> 6 KB

Read more
2026-06-08 12:00

Hyperion DeFi Reiterates Guidance on Sunset of USDH and Felix Markets

Read more